远端脾肾静脉分流手术治疗肝外型门脉高压的探讨

目的探讨保留脾脏、远端脾静脉肾静脉分流手术治疗肝外型门脉高压的效果。方法本组手术患儿15例,术前经多普勒超声检查门静脉主干呈海绵窦样改变。术中首先经小肠系膜Ⅲ级静脉和脾静脉分支行静脉压力测定及造影。然后将胰腺上下缘及背侧游离;将胰腺内走行的脾静脉游离,结扎切断与胰腺之间的细小分支,远端至脾静脉与肠系膜上静脉或肠系膜下静脉汇合处,近端至脾门;最后将脾静脉距肠系膜上或下静脉0.5cm处切断,闭合肠系膜上静脉侧断端,将脾静脉与左肾静脉端一侧吻合;同时结扎胃冠状静脉、胃左静脉和胃网膜左静脉而保留胃短血管。结果15例患儿实施远端脾-肾分流手术,手术时间平均3.5h,手术失血10～30ml;无需输血者。分流前肠系膜上静脉和脾静脉压力平均值分别为28.4cmH2O和28.1cmH2O,分流后平均值分别为24.7cmH2O和12.6cmH2O,脾静脉压力明显降低(P<0.01)。分流后脾脏缩小,被膜皱缩。2例手术后患儿出现乳糜腹,保守治疗1个月后自然消失。患儿随诊6个月～2年无再发消化道出血者,脾脏大小均回缩。血红蛋白、白细胞、血小板均在正常水平。超声多普勒检查,脾肾静脉吻合口通畅。结论远端脾静脉-肾静脉分流术是治疗小儿肝外型门静脉高压的有效途径之一,具有保留脾脏,贲门胃底血液可通过胃短动脉流向脾静脉使该区域保     

Warren手术治疗小儿门脉高压症50例分析

目的 探讨保留脾脏、远端脾静脉肾静脉分流手术（Warren手术）治疗小儿门脉高压症的临床效果.方法 1999年10月至2012年12月,我们收治门脉高压症患儿50例,年龄3～15岁.男18例,女32例.患儿表现为反复消化道出血,食管静脉曲张,脾功能亢进.门静脉主干呈海绵窦样改变36例,Carolis病合并肝纤维化3例,先天性肝纤维化9例,门静脉发育不良1例,门静脉海绵样变Rex术后复发1例.Child-pugh评分均为A级（5～7分）,脾静脉直径6.0 ～ 15.0 mm,平均（9.8±2.2）mm.术中先经小肠系膜Ⅲ级静脉和脾静脉分支行静脉压力测定及造影,将脾静脉游离,于距肠系膜下静脉0.5 cm处切断,与左肾静脉端-侧吻合.结果 所有患儿实施远端脾-肾分流手术,手术时间255～ 370 min,平均手术时间232 min,术中失血10～ 30 mL.分流后门静脉和脾静脉压力均下降,门静脉压力分流后较分流前显著降低（P=0.026）;脾静脉压力分流后较分流前明显降低（P =0.007）.迄今为止随访时间跨度为0.5～11年.随访期间,患儿脾脏缩小,血红蛋白、白细胞、血小板恢复正常,无一例出现脑病.B超检查显示49例脾肾静脉吻合口通畅,1例术后1个月发现脾肾吻合口闭合,经再次手术治疗痊愈.结论 Warren手术治疗小儿门脉高压症效果显著,能有效降低小儿门脉高压术后食管静脉曲张再出血的发生率,保证入肝血流,减少肝性脑病的发生,是治疗小儿门脉高压症较理想的术式.     

肠系膜上静脉门静脉左支分流术治疗肝外门脉高压

目的 探讨肠系膜上静脉门静脉左支分流术治疗肝外门静脉梗阻的效果.方法 2008年10月至2010年2月对12例肝外门脉梗阻并门脉高压患儿实施肠系膜上静脉门静脉左支分流术(mesenteric-to-left portal vein bypass,MLPVB;又称Rex Shunt,RS手术).2例因门静脉左支闭锁,无法吻合,实施远端脾肾分流术(Warren手术).RS手术患儿年龄1.6～12岁,平均(5.6±3.3)岁.男8例,女2例.7例患儿有反复呕血、黑便史,输血史,输血量800～2400 ml;另外3例患儿表现巨脾、脾功能亢进、进行性贫血.8例患儿术前红细胞、白细胞、血小板降低;2例AST轻度升高,1例TBIL轻度升高,其他患儿各项指标正常;无脑病表现.术前影像学检查提示:10例表现食道胃底静脉曲张,门脉海绵样变;脾脏增大,脾脏平均长径(n=8)(12.4±0.8)cm,厚度(5.1±0.57)cm.手术采用上腹肋缘下横切口,测定肠系膜上静脉压力,并行门脉造影.分离矢状部肝组织,游离肝门静脉左支,穿刺测压并造影,确认门静脉左支通畅,阻断钳阻断并纵行劈开矢状部.根据门脉造影及探查情况选择游离胃冠状静脉、或脾静脉或移植一段合适的回肠静脉.然后以6-0 Prolene线将胃冠状静脉、脾静脉与门静脉左支行端侧吻合,移植血管一端与门静脉左支矢状部吻合另一端与门静脉远端吻合.再次测定肠系膜上静脉压力,并行血管造影.术后随访4～20个月.结果 10例患儿均成功实施手术,平均手术时间(220±14.7)min,出血约10～50 ml,分流完成后造影显示分流血管均通畅无狭窄.分流前门脉平均压力(38.3±7.2)cm H2O,分流后降为平均(27.2±5.3)cm H2O,(P=0.001).平均住院时间(10±1.9)d.随访期间无患儿再出现呕血,影像学检查分流血管通畅,肝功能各项指标正常;血小板、红细胞血红蛋白、白细胞正常;脾脏较术前缩小,脾脏平均长径(n=8)(10.2±0.5)cm,较术前缩小(P=0.00),平均厚度(3.6±0.2)cm,较术前缩小(P=0.000),门静脉左支直径增大.结论 Rex分流术治疗门静脉海绵样变性安全、可行、效果良好.     

儿童门静脉海绵样变18例诊疗分析

目的探讨儿童门静脉海绵样变的临床特点及治疗方式。方法回顾性分析2012年至2018年浙江大学医学院附属儿童医院收治的18例门静脉海绵样变患儿临床资料、手术方式及预后情况,并进行总结分析。结果本组18例均手术成功。其中5例行Rex手术,选择的分流血管包括肠系膜上静脉、胃冠状静脉、胃右静脉以及门静脉扩张最显著的侧支血管。行Rex手术的患儿有1例术后因消化道出血、脾功能亢进而再次接受手术,发现为吻合口狭窄,术中切除狭窄段,取管径较大的一段空肠系膜血管作为补片搭桥,同时行食管胃底静脉结扎术。5例行Warren手术的患儿术后恢复良好,无一例消化道出血,脾功能亢进、脾大现象均明显改善,术后无一例并发症。4例行近端脾肾分流术(其中1例术后反复消化道出血,于二次手术时行肠系膜上静脉-下腔静脉分流术)。3例行肠系膜上静脉-下腔静脉分流术,同时切除脾脏,术后出现消化道出血,保守治疗后病情得到控制。结论儿童门静脉海绵样变需早期诊断,选择恰当的治疗措施对改善患儿的预后非常重要。外科治疗方法的选择应根据患儿的病情及门静脉系统血管的条件来决定,其中Rex手术是儿童门静脉海绵样变的首选治疗方法,此外Warren手术和近端脾肾分流术也是较为理想的术式。     

肠门分流（Rex手术）治疗肝外型门静脉高压的初步研究

目的探讨肠系膜上静脉门静脉左支分流术（Rex手术）治疗门静脉海绵样变的临床效果：方法2008年10月至2009年9月本院共收治6例门静脉海绵样变性并门脉高压患儿。年龄20～82个月,均为男性。4例有反复上消化道出血、呕血、输血史,输血量800～2400mL;2例表现为巨睥、脾功能亢进、进行性贫血。5例患儿术前红细胞、白细胞、血小板不同程度降低;肝功能各项指标均正常。术前影像学检查提示：食管胃底静脉曲张,门脉海绵样变;脾脏增大。手术采用上腹肋缘下横切口,测定肠系膜上静脉压力,并行门静脉造影。游离胃冠状静脉达食管裂孔水平,离断。游离肝门静脉左主支,阻断并纵行劈开矢状部,然后以6-0Prolene线将胃冠状静脉与门静脉左支行端侧吻合。再次测定肠系膜上静脉压力,并行血管造影。术后随访3～11个月。结果6例均成功实施手术,手术时间200．240min,出血约20～30mL,分流完成后造影显示分流血管均通畅无狭窄。分流前门静脉压力39～53cmH2O,分流后降为29～32cmH2O。术后住院时是7～12d：随访期间患儿未再出现呕血,影像学检查显示分流血管通畅,肝功能各项指标正常;血小板、红细胞、血红蛋白、白细胞正常;脾脏较术前缩小,厚度3．5～4．0cm。结论Rex分流术治疗门静脉海绵样变性安全、可行,效果良好。     

门静脉主干-门静脉右支搭桥治疗门静脉海绵样变

目的 Rex手术(肠系膜上静脉与门静脉左支矢状部搭桥分流手术)是治疗肝外门静脉海绵变导致门静脉高压的最流行术式,但是有大约14％的患者合并有门静脉矢状部闭锁或发育不良不能行此分流手术,并且此手术后的失败率在4％～28％,这限制了这种符合生理性分流手术的应用.本研究的目的是探索向肝内门静脉右支分流建立恢复门静脉血流的新途径.方法 2015年11月至2016年6月,对4例门静脉海绵样变性行Rex分流手术后门脉高压复发患儿行门静脉右支分流手术.患几年龄3.5～8.9岁,平均6.1岁,分别于1.1～2.5年前在我院行Rex手术,其中采用扩张的胃冠状静脉与肝内门静脉矢状部搭桥3例,扩张的门静脉主干分支与肝内门静脉矢状部搭桥1例,术后再发出血和脾功能亢进,经保守治疗无效.术前影像学检查提示:食管胃底静脉曲张,门静脉海绵样变存在;原搭桥血管显示不清,肝内门静脉血流少;脾脏增大.手术采用原上腹肋缘下横切口,首先游离肝门的了解原搭桥血管的形态;然后将胆囊从胆囊床上游离;在右侧肝门的后方切开Glisson氏鞘,显露门静脉右支,将其游离足够的长度;然后切开肝十二指肠韧带,游离扩张门静脉主干足够的长度;根据肝内门静脉右支至肝外门静脉主干之间的距离,截取肠系膜下静脉作为搭桥血管:血管壁外观正常,直径≥5 mm;以7-0 Prolene线将间置静脉的近心端和远心端分别与门静脉右支和肝外门静脉的主干行端侧吻合.术后1个月、3个月及6个月定期随访.结果 4例患儿中3例门静脉右支发育好、通畅,直径5～6 mm,成功实施门静脉右支搭桥手术;另外1例门静脉右支纤细放弃搭桥.手术时间2.3 h(1.9～3.5 h),术中出血约50 ml(30～80 ml),无一例需要输血.取肠系膜下静脉间置3例;搭桥后门静脉的平均压力由33 cmH2 O(26～45 cmH2 O)下降至18.7 cmH2O(14～24 cmH2O).术中发现肝内门静脉右支与左支延续相通,而与肝外门静脉主干中断不通;Glisson鞘内沿着胆管周围大量增生的小静脉;原搭桥血管呈条索状,一致性狭窄或闭锁.术后随访6～18个月,无患儿再出现呕血,影像学检查分流血管增粗通畅,肝内门静脉增粗,门静脉海绵样改变消失,肝功能各项指标正常;血小板、红细胞血红蛋白、白细胞正常.结论 门静脉主干与肝内门静脉右支分流是治疗肝外型门静脉高压的有效新方法,适用于门静脉左支发育不良或Rex手术失败的病例,目前该方法尚未见文献报告.     

颈内静脉搭桥Rex手术治疗小儿肝外门静脉梗阻的初步探讨

目的 探讨颈内静脉搭桥Rex手术(肠系膜上静脉-门静脉左支吻合术)治疗小儿肝外门静脉梗阻的手术效果.方法 2014年10月至2015年6月共收治肝外门静脉梗阻8例,行颈内静脉搭桥Rex手术治疗,随访1～9个月,评价手术效果.手术方法:取上腹正中纵行切口,首先切断肝圆韧带,并沿其向Rex窝分离,解剖出门静脉左支矢状部3 cm;沿结肠中血管找到肠系膜上静脉,分离出3 cm;取左侧颈部横切口,切取颈内静脉7～9 cm.将颈内静脉在门静脉左支和肠系膜上静脉之间搭桥行两个端侧吻合.结果 8例中男5例,女3例,平均年龄4岁(1岁4个月至7岁),表现为消化道出血6例,脾功能亢进6例,出血合并脾亢4例.术前肝功能及凝血大致正常,胃镜检查7例食管胃底静脉曲张,1例无曲张.超声及CT均诊断门静脉海绵样变性;行经肝静脉逆行门静脉系统造影,显示门静脉左支矢状部存在7例,未显示1例(术中证实为闭锁).7例手术探查Rex窝内有血流,完成Rex手术,1例门静脉左支闭锁,改行Warren手术.吻合后经肠系膜上静脉造影显示搭桥血管通畅,肝内门静脉系统显影,肝外侧枝曲张血管明显减少或未显示.吻合后门静脉压力明显降低,吻合前PVP为(27.00±3.74)mmHg,吻合后PVP为(19.00±2.71)mmHg,吻合前后PVP压力差为(8.00±3.42)mmHg,P=0.001.术后随访,全部患儿无再次出血,6例术前脾亢患儿5例得到缓解,1例未缓解;3例于术后半年复查胃镜,食管胃底静脉曲张由重度转为轻-中度;超声检查门静脉血流均通畅,无血栓及狭窄,术后门静脉左支直径为(7.10±2.47)mm(3.3～10.5 mm).结论 Rex手术对于小儿门静脉梗阻具有良好治理效果,在降低门静脉压力的同时,恢复了肝脏血流,是EHPVO根治性手术方式,应该作为治疗小儿肝前性门静脉高压的首选手术方法.     

Rex术后再发生上消化道出血的治疗策略探讨

目的 探讨小儿肝外门静脉高压Rex术后再发生上消化道出血时的治疗策略.方法 回顾性分析2008年6月至2017年1月126例门静脉海绵样变行Rex手术治疗患儿中,26例Rex术后再次出现呕血、黑便等上消化道出血表现患儿的临床资料.其中,113例患儿门静脉血管超声和CT显示未见明显分流血管,10例分流血管明显狭窄,3例门静脉血管超声可见分流血管通畅.21例患儿行上消化道造影检查,其中20例食管静脉曲张.采用输血止血等保守治疗10例.行Warren术治疗5例,其中1例先行Rex术治疗失败后改行Warren术.行Rex术治疗8例,其中1例失败,最终行Warren术治疗;1例先行内镜下硬化剂治疗后再出血,改行Rex术治疗.行肠系膜下静脉间置、门静脉主干-门静脉右支分流术1例.1例吻合口狭窄患儿行吻合口扩大成形术.行内镜下硬化剂治疗3例,1例术后再次出血后行Rex术治疗.所有患儿定期随访及复查.结果 行Rex术、Warren术和保守治疗患儿上消化道出血复发率分别为62.5％ (5/8)、20％(1/5)和90％(9/10),食道胃底静脉曲张率分别为75％(6/8)、20％(1/5)和100％,均以行Warren术患儿最低,三组比较,差异均有统计学意义(P=0.027和0.015).比较行Rex术、Warren术和保守治疗患儿术后随访时间[(22.9±24.4)个月、(26.6±24.1)个月和(26.0±20.4)个月],三组差异无统计学意义(P=0.939).行Rex术和Warren术患儿术后分流血管通畅率分别为62.5％(5/8)和100％,组间差异无统计学意义(P=0.118).保守治疗10例,其中1例分流血管通畅者迄今随访43个月未再出血,其余患儿均出现呕血或黑便.接受内镜下硬化剂治疗3例,其中1例分流血管闭锁者术后再次呕血行Rex手术治疗.结论 Warren术是治疗Rex术后复发的有效手术方法.保守治疗及内镜下硬化剂治疗仅适用于分流血管通畅的患儿,对于分流血管狭窄或闭锁的患儿应积极手术治疗.     

小儿门静脉海绵样变术后并发乳糜腹水临床分析

目的 本文探讨小儿门静脉海绵样变术后并发乳糜腹水的发病原因,预防措施及治疗方法.方法 回顾性分析本院5年间收治因门静脉海绵样变门脉高压而反复上消化道出血患儿9例,均行手术治疗,术后4例出现乳糜腹,其中2例发生于脾脏切除加脾肾静脉分流术后,1例发生于肠系膜上静脉下腔静脉分流术后,1例发生于Warren术后.结果 4例乳糜腹水患儿有3例经过禁食及TPN等保守治疗后在术后1～4周乳糜腹水消失,1例患儿经过4周保守治疗后每天仍有2000 ml左右的乳糜腹水,在术后4周行腹腔大隐静脉转流术,术后1周乳糜腹水消失.随访1～6年,均无复发.结论 门静脉海绵样变术后并发乳糜腹水的主要原因为术中损伤淋巴管或乳糜池,保守治疗有效,必要时可手术治疗.     

保留脾上极脾-肾静脉分流治疗小儿门静脉海绵窦样变二例

门静脉海绵窦样变是小儿肝前性门脉高压症的常见原因,晚期反复出现食管胃底静脉破裂出血是临床治疗难点,这类患儿常常采用断流手术以期阻断异常血流达到止血目的,但效果差强人意.国外多中心较早开展门-腔静脉转流手术治疗,降低门静脉压力,达到了防治出血的目的[1,2].但断流手术以及脾-腔、脾-肾静脉转流手术,均同时行脾脏切除术.脾切除术后带来的严重感染风险、免疫功能缺失等,尤其在小儿,仍是一项挑战.近期我科先后采取保留脾脏上极的脾-肾静脉分流的手术方法治疗门静脉海绵窦样变2例,取得了满意效果,报告如下.     

儿童门静脉海绵样变性的临床特点及手术治疗策略CSCD

目的探讨儿童门静脉海绵样变性的临床特点及手术治疗策略。方法回顾性分析湖南省儿童医院2010年5月至2022年1月收治的27例儿童门静脉海绵样变性患儿临床资料,其中男12例,女15例;年龄1岁7个月至11岁11个月。患儿均经腹部超声及CT检查确诊为儿童门静脉海绵样变性,并经数字减影血管造影(digital subtraction angiography,DSA)评估肝内外门静脉通畅情况,根据病变情况选取手术方式。结果27例患儿均实施手术。其中Rex手术19例,行Rex手术的患儿术后门静脉系统压力均明显下降;其中2例利用粗大肝外侧支静脉与门静脉矢状部行侧侧吻合,肝内门静脉获得满意灌注量;1例行巨脾切除后利用脾静脉行经典Rex手术;2例搭桥血管血栓形成,经抗凝治疗后失败,血管闭塞。3例因严重门静脉海绵样变性和反复消化道出血实施肝移植手术,其中1例早期发生肝动脉血栓,经抗凝治疗后再通。3例实施远端脾肾分流手术,分流血管通畅。2例实施近端脾肾分流手术,其中1例出现脾静脉附壁血栓,经抗凝治疗后好转。结论儿童门静脉海绵样变性常常以门脉高压相关症状为临床特点,手术方式应根据肝内外门静脉发育和代偿情况综合分析后进行选择,搭桥血管可以根据患儿自身血管特点进行选择。首选Rex手术的原因在于其能够恢复门静脉系统正常解剖通道和生理作用,改善肝脏灌注和生长发育,避免肝性脑病的发生。     

Control of bleeding in extrahepatic portal hypertension--the reverse splenorenal shunt and portal-azygos disconnection

Variceal bleeding in children with extrahepatic portal hypertension is best controlled by an effective decompressive shunt. Both the standard and central splenorenal shunts require splenectomy which is undesirable in childhood, and alternative shunts such as the mesocaval shunt and the distal splenorenal shunt are also technically difficult with a similar risk of shunt thrombosis. The reverse splenorenal shunt first described in 1962 by Erlik uses the proximal portion of the left renal vein which was initially anastomosed to the portal vein. It can be anastomosed to any of the major tributaries of the portal system. In the technique described, the proximal end of the renal vein is joined to the side of the splenic vein continuity. It is preferable for this to be done as an elective planned procedure. Massive continuing haemorrhage which is not responding to conservative management can be controlled by portal-azygos disconnection with gastric transection. This procedure will control major variceal haemorrhage for several years and allow a decompressive shunt to be performed under optimal conditions and after appropriate preoperative investigations.     

Control of bleeding in extrahepatic portal hypertension — the reverse splenorenal shunt and portal-azygos disconnection

Abstract Variceal bleeding in children with extrahepatic portal hypertension is best controlled by an effective decompressive shunt. Both the standard and central splenorenal shunts require splenectomy which is undesirable in childhood, and alternative shunts such as the mesocaval shunt and the distal splenorenal shunt are also technically difficult with a similar risk of shunt thrombosis.
The reverse splenorenal shunt first described in 1962 by Erlik uses the proximal portion of the left renal vein which was initially anastomosed to the portal vein. It can be anastomosed to any of the major tributaries of the portal system. In the technique described, the proximal end of the renal vein is joined to the side of the splenic vein in continuity. It is preferable for this to be done as an elective planned procedure. Massive continuing haemorrhage which is not responding to conservative management can be controlled by portal-azygos disconnection with gastric transection. This procedure will control major variceal haemorrhage for several years and allow a decompressive shunt to be performed under optimal conditions and after appropriate preoperative investigations.     

临时性门腔静脉架桥联合流出道改良重建在部分供肝肝移植中应用的实验研究

目的 通过动物肝移植实验,探索门腔静脉架桥和改良肝静脉出口重建这一联合方法的可行性及价值.方法 选择20～25 kg和10～15 kg健康杂交犬各12只,组成供体组和受体组,并随机配对.供体手术取左外侧叶及左中央叶为供肝,然后完全阻断门静脉.受体犬先预置门腔静脉之间端侧吻合架桥的分流通道,切肝门静脉阻断时开放,供肝植入...     

Extrahepatic portal hypertension in children: observations on three surgical procedures

This paper presents a comparative prospective study of three modalities of surgical treatment for extrahepatic portal hypertension in children: central splenorenal shunt after splenectomy (CSS), side-to-side lienorenal shunt (SSLR) without splenectomy, and splenectomy and gastroesophageal devascularization (SGD). In an 18-month period, 27 procedures were performed: 10 CSS, 10 SSLR, and seven SGD. The outcomes were evaluated by fall in portal pressures, hematological parameters, shunt patency, splenic regression, and disappearance of esophageal varices. All three procedures were comparable in the fall of portal pressure after surgery. The average blood loss and operating time were statistically significant in favor of SSLR compared with CSS. At 3-month follow-up, shunt patency was confirmed by duplex Doppler study in all the patients in the SSLR group and in nine out of 10 patients in the CSS group. In the CSS and SGD groups, hypersplenism resolved in all the patients. In the SSLR group, blood counts improved in only five out of eight affected children. No patient re-bled during a follow-up of 3–5 years. There were no cases of hepatic encephalopathy or overwhelming postsplenectomy sepsis. In conclusion, CSS is useful when there is a large spleen, severe hypersplenism, and a shuntable splenic vein. SSLR is suitable when there is only mild splenomegaly, mild hypersplenism, and a shuntable splenic vein. Splenectomy and devascularization is the choice when there is no shuntable splenic vein.     

Portosystemic shunting in children during the era of endoscopic therapy: improved postoperative growth parameters

BACKGROUND: Surgical portosystemic shunting has been performed less frequently in recent years. In this retrospective study, recent outcomes of portosystemic shunting in children are described, to evaluate its role in the era of endoscopic therapy. METHODS: Retrospective chart review of children who underwent surgical portosystemic shunt procedures between October 1994 and October 1997. RESULTS: Twelve children (age range, 1-16 years) underwent shunting procedures. The causes of portal hypertension were extrahepatic portal vein thrombosis (n = 6), congenital hepatic fibrosis (n = 2), hepatic cirrhosis (n = 2), and other (n = 2). None of the patients were immediate candidates for liver transplantation. Types of shunt included: distal splenorenal (n = 10), portocaval (n = 1), and other (n = 1). Median follow-up was 35 months (range, 24-48 months). All patients are currently alive and well with patent shunts. The mean hospital stay was 8 days. Three patients required readmission for further interventions because of shunt stenosis in two and small bowel obstruction in the other. Mild portosystemic encephalopathy was seen in one child with pre-existing neurobehavioral disturbance. Excluding a patient who underwent placement of a portosystemic shunt for a complication of liver transplantation, mean weight-for-age z score in nine prepubertal patients improved from -1.16 SD to +0.15 SD (P = 0.023), and mean height-for-age z score from -1.23 SD to 0.00 SD (P = 0.048) by 2 years after surgery. CONCLUSIONS: Surgical portosystemic shunting is a safe and effective method for the management of portal hypertension in childhood. Patients show significant improvements in growth parameters after the procedure. Surgical portosystemic shunting should be actively considered in selected children with portal hypertension.